DOI 10.1097/ms9.0000000000005251
Assessment of chemotherapy-associated sarcopenia using SARC-F and handgrip strength: a cross-sectional analysis.
Аннотация
BACKGROUND
Sarcopenia is a significant health concern among patients with cancer who receive chemotherapy due to its potential impacts on treatment tolerance and functional status.
OBJECTIVES
To explore the association between chemotherapeutic agents and practical sarcopenia markers, including SARC-F scores and grip strength, among oncology outpatients with advanced cancer, and to explore the relationship between chemotherapy exposure (cycle number) and functional muscle decline.
METHODS
A secondary analysis of a primary cross-sectional dataset of 324 patients who attended outpatient clinics at Princess Noorah Oncology Center, Jeddah. Sarcopenia was assessed via the SARC-F questionnaire and digital grip strength measurement. Associations between chemotherapeutic agents and sarcopenia markers were evaluated using inferential analyses, and agents showing significant bivariate associations were further analyzed using multiple linear regression.
RESULTS
Among chemotherapeutic agents, paclitaxel was independently associated with higher SARC-F scores (β = 1.19, 95% CI: 0.26-2.12, P = 0.013) and significantly lower grip strength (median: 28.1 kg vs. 41.3 kg, P < 0.001). Vinblastine showed a negative association with SARC-F in unadjusted analysis (P = 0.025), but not after adjustment (P = 0.269). No significant correlations were found between the number of chemotherapy cycles and either grip strength (R = 0.099, P = 0.212) or SARC-F score (R = 0.066, P = 0.405).
CONCLUSION
Paclitaxel use is an independent predictor of functional decline in cancer patients, highlighting the need for early sarcopenia screening and tailored supportive care during taxane-based chemotherapy.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.